ArticlePloS one2018

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?

Stefan Garczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.